18 March 2010

MediLink Global UK seeks China growth

14/11/2008 Robert Tyerman

Malaysian electronic ‘healthcare card’ pioneer MediLink Global UK is bravely seeking £2m at 18p on AIM to grow in China.

The Jersey-domiciled company, whose proprietary software instantly connects hospitals, doctors, dentists and other medical providers with medical insurers, employers and governments to process treatment claims via a credit card-type terminal, has so far distributed 1.8 million cards to 100 private hospitals in Malaysia.

MediLink, which turned a £22,000 loss into a £137,000 pre-tax profit last year, now claims 90% of Malaysia’s private hospital market and is poised to expand into the potentially massive Chinese market after signing a contract with Ping An, the People’s Republic’s second-largest life insurer.

Co-founder and chief executive officer Shia Kok Fat suggests Ping An’s 1,500 regional offices and 300,000 sales agents should put MediLink in a strong position to gain a significant role in China’s burgeoning medical insurance market.

He wants the company, whose chairman is Norman Lott (finance director of loss-making AIM biotech dog ReGen Therapeutics), to attack other markets in the region to establish itself as a recognised ‘third-party administrator’ and corporate client server on this sector throughout South-East Asia.

Dowgate Capital is nominated adviser to MediLink, whose broker is SV Securities. Directors own 70 per cent of the company, which scored last year’s turnaround on sales increased 57% to £644,000. Fans argue this type of insurance market, especially in that part of the world, is counter-cyclical, or even non-cyclical, and suggest further hefty profits and sales gains are on the cards for 2008.

There is clearly an element of risk in MediLink’s ambitious strategy. But bold investors still willing to have a go might consider a punt.

Save 50% off your first year’s subscription to Growth Company Investor magazine, and gain immediate access to all the recommendations online. Click here.

Sector: Health Care Equipment & Services

Subscribe today

£7,277

That’s what you would have in your portfolio if you had invested £6,000 into the six Company Watch recommendations in our April 2009 issue.

Subscribe now and receive a 50% discount

AIM in Review 2010

Growth Company Investor, in association with the London Stock Exchange, presents the most wide-ranging and detailed examination of the AIM market: AIM in Review 2010. For more information and to order, click here or contact our marketing team on 020 7250 7056.

Directors' Pay on AIM 2009 – ­ a Growth Company Investor publication in association with Deloitte

The report reveals the top-earning chief executives and remuneration levels at AIM's most profitable and fastest-growing companies. It also examines constituent parts, including basic salary, bonus, pensions, benefits and share-based payments. To order click here.

Free – Latest Stock Recommendations

Free access to the latest AIM stock recommendations and news from the award-winning Growth Company Investor team. Receive our tips on what stocks to buy direct to your inbox every Tuesday and Friday. Find out more today.

Select your level of risk and we select the funds

Cautious? Positive? Adventurous? Choose between three levels of risk for a fund of funds from Sharefunds, our sister company. Click here for more information.

The AIM Guide 2009/10

The brand new, fully updated AIM Guide 2009/2010 is now available to purchase. AIM Guide is the only fully comprehensive guide to AIM and is regarded as 'must-have' for any serious investor or professional interested in the market for young, fast-growing companies.   Order your copy today and benefit from a £10 discount!

VCT Special Report 2009

This report's principal aim is to provide business owners seeking funding with information about the amount of funds that VCTs have to invest. Click here for more information.

Cash Shells Special Report 2009

Business XL, the award-winning monthly magazine for growing companies, is delighted to announce the launch of a new study on cash shells. The research provides a comprehensive overview of cash shells on AIM, companies that have become a significant feature on the AIM landscape. Buy the Cash Shells 2009 Research Report today or email Halid Delkic to obtain a free two-page abstract.

Latest small-cap and growth company news

Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.

Popular News

Latest News

Turnaround at TEG 17/03/2010

Organic composting specialist TEG Group is pursuing long-term contracts after turning £1.6 million annual losses into £155,000 pre-tax profits.

Tags: AIM , Growth Stocks , Mergers & acquisitions , Turnaround

Sector: General Industrials

Companies: TEG (formerly TEG Environmental)

Cyprotex broadens its scope 17/03/2010

Bid candidate Cyprotex is moving its drug discovery services into toxicology after pre-tax profits down 15 per cent to £460,413.

Tags: AIM , Cash , Mergers & acquisitions

Sector: Pharmaceuticals & Biotechnology

Companies: Cyprotex

West African hopes cheer Forte 16/03/2010

Forte Energy expects new uranium resource figures for its Mauritanian projects shortly and could start producing from Guinea by 2012.

Tags: AIM , Commodities , Deals & contracts

Sector: Mining

Companies: Forte Energy

More News

Sectors

Vitesse Media Events